Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neuro-Oncology Advances|November 18, 2024
Biological and prognostic relevance of epigenetic regulatory genes in high-grade gliomasSonikpreet Aulakh, Joanne Xiu, Andrew Hinton, et al.
Gynecologic Oncology|May 9, 2025
Whole-exome sequencing provides assessment of homologous recombination deficiency for identification of PARPi-responsive ovarian tumorsElizabeth Evans, Jhalak Dholakia, Jim Abraham, et al.
The Journal of Biological Chemistry|March 23, 2006
Quaternary ammonium compounds as water channel blockers. Specificity, potency, and site of actionFrank J M Detmers, Bert L de Groot, E Matthias Müller, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 30, 2015
The stretch responsive microRNA miR-148a-3p is a novel repressor of IKBKB, NF-κB signaling, and inflammatory gene expression in human aortic valve cellsVishal Patel, Katrina Carrion, Andrew Hollands, et al.
Endocrine-Related Cancer|June 13, 2025
Targeting anti-apoptosis as a therapeutic strategy in neuroendocrine neoplasmsVineeth Sukrithan, Uzair Ahmed, Harris Krause, et al.
RNA (New York, N.Y.)|April 24, 2015
Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinomaAngela E Zou, Jonjei Ku, Thomas K Honda, et al.
Cancers|December 30, 2025
Real-World Impact of Metformin on Outcomes in Patients with Deficient DNA Mismatch Repair and Microsatellite Instability (dMMR/MSI) Colorectal Cancer Treated with Immune Checkpoint InhibitorsGarima Gupta, Negar Sadeghipour, Fuat Bicer, et al.
BMJ Oncology|April 8, 2026
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancerSepideh Gholami, Anwaar Saeed, Yasmine Baca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic AdenocarcinomaBach Ardalan, Aaron Ciner, Yasmine Baca, et al.
The Oncologist|April 30, 2026
Proactive Identification of Candidates for Newly-Approved Targeted Therapies Using a Clinical Decision Support ProgramRebecca Feldman, Farah Abdulla, Andrew Hinton, et al.
Pageof 3